203 related articles for article (PubMed ID: 2045130)
21. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
Patel DM; Mannie MD
Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
[TBL] [Abstract][Full Text] [Related]
22. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
Guidos C; Sinha AA; Lee KC
Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
[TBL] [Abstract][Full Text] [Related]
23. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
[TBL] [Abstract][Full Text] [Related]
25. Antigen-presenting function of the macrophage.
Unanue ER
Annu Rev Immunol; 1984; 2():395-428. PubMed ID: 6242349
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation.
Schirmbeck R; Melber K; Reimann J
Eur J Immunol; 1995 Apr; 25(4):1063-70. PubMed ID: 7537671
[TBL] [Abstract][Full Text] [Related]
27. Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells.
Krieger J; Jenis DM; Chesnut RW; Grey HM
J Immunol; 1988 Jan; 140(2):388-94. PubMed ID: 2961812
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
Whalen BJ; Tony HP; Parker DC
J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
[TBL] [Abstract][Full Text] [Related]
29. T cell tolerance to kappa light chain (L kappa): identification of a naturally processed self-C kappa-peptidic region by specific CD4+ T cell hybridomas obtained in L kappa-deficient mice.
Faure M; Sanchez P; Cazenave PA; Rueff-Juy D
Cell Immunol; 1997 Aug; 180(1):84-92. PubMed ID: 9316642
[TBL] [Abstract][Full Text] [Related]
30. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
31. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
Rock KL; Rothstein L; Gamble S; Fleischacker C
J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
[TBL] [Abstract][Full Text] [Related]
32. Processing and presentation of type II collagen, a fibrillar autoantigen, by H-2q antigen-presenting cells.
Manoury-Schwartz B; Chiocchia G; Fournier C
Eur J Immunol; 1995 Dec; 25(12):3235-42. PubMed ID: 8566006
[TBL] [Abstract][Full Text] [Related]
33. Differential APC requirements of self- and nonself-reactive T cells and T cell hybridomas specific for retinal S-antigen.
Prasad SA; Fling SP; Gregerson DS
J Autoimmun; 1997 Feb; 10(1):1-9. PubMed ID: 9080294
[TBL] [Abstract][Full Text] [Related]
34. Immunodominance does not result from peptide competition for MHC class II presentation.
Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
[TBL] [Abstract][Full Text] [Related]
35. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect.
Ashwell JD; Jenkins MK; Schwartz RH
J Immunol; 1988 Oct; 141(8):2536-44. PubMed ID: 2844902
[TBL] [Abstract][Full Text] [Related]
36. Antigen presenting cells and mechanisms of antigen presentation.
Chesnut RW; Grey HM
Crit Rev Immunol; 1985; 5(3):263-316. PubMed ID: 3884274
[TBL] [Abstract][Full Text] [Related]
37. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
38. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
Casten LA; Pierce SK
J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
[TBL] [Abstract][Full Text] [Related]
39. Activation requirements of cloned inducer T cells. II. The failure of some clones to respond to antigen presented by activated B cells.
Dekruyff RH; Cantor H; Dorf ME
J Immunol; 1986 Jan; 136(2):446-51. PubMed ID: 3484492
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal c-myc transformed macrophage cell lines. I. Heterogeneity in ability to process and present antigen.
Trannoy E; Manser T; Cole MD; Daley MJ
J Immunol; 1993 Sep; 151(6):3042-56. PubMed ID: 8104218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
